6092 — Enbio Holdings Cashflow Statement
0.000.00%
- ¥5bn
- ¥12bn
- ¥11bn
- 22
- 76
- 47
- 46
Annual cashflow statement for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 488 | 1,099 | 1,233 | 1,066 | 702 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 102 | 98.5 | 127 | -298 | 79.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -660 | 873 | 229 | 506 | -1,258 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 297 | 2,413 | 1,989 | 1,712 | 22.4 |
Capital Expenditures | -1,731 | -1,165 | -1,165 | -1,079 | -1,467 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -429 | -316 | -605 | -505 | -136 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,160 | -1,481 | -1,770 | -1,584 | -1,603 |
Financing Cash Flow Items | — | -86.4 | -22.2 | -50.8 | -70.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 929 | -535 | 241 | 639 | 1,274 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -966 | 356 | 457 | 775 | -311 |